{
  "id": "57136cbf1174fb1755000007",
  "type": "yesno",
  "question": "Can fetal aneuploidy be detected with non-invasive prenatal testing?",
  "ideal_answer": "Yes, the non-invasive preanatal test of cell-free fetal DNA is being used for fetal aneuploidy screening.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/22500971",
    "http://www.ncbi.nlm.nih.gov/pubmed/23765643",
    "http://www.ncbi.nlm.nih.gov/pubmed/25044397",
    "http://www.ncbi.nlm.nih.gov/pubmed/23712453",
    "http://www.ncbi.nlm.nih.gov/pubmed/24603453",
    "http://www.ncbi.nlm.nih.gov/pubmed/25543032",
    "http://www.ncbi.nlm.nih.gov/pubmed/23553438",
    "http://www.ncbi.nlm.nih.gov/pubmed/25138112",
    "http://www.ncbi.nlm.nih.gov/pubmed/24312358",
    "http://www.ncbi.nlm.nih.gov/pubmed/23299662",
    "http://www.ncbi.nlm.nih.gov/pubmed/22863603",
    "http://www.ncbi.nlm.nih.gov/pubmed/24783433",
    "http://www.ncbi.nlm.nih.gov/pubmed/23089167",
    "http://www.ncbi.nlm.nih.gov/pubmed/26252102",
    "http://www.ncbi.nlm.nih.gov/pubmed/17186566",
    "http://www.ncbi.nlm.nih.gov/pubmed/10655451",
    "http://www.ncbi.nlm.nih.gov/pubmed/24352524",
    "http://www.ncbi.nlm.nih.gov/pubmed/24482806",
    "http://www.ncbi.nlm.nih.gov/pubmed/25449088",
    "http://www.ncbi.nlm.nih.gov/pubmed/24990604",
    "http://www.ncbi.nlm.nih.gov/pubmed/23526649",
    "http://www.ncbi.nlm.nih.gov/pubmed/26080919",
    "http://www.ncbi.nlm.nih.gov/pubmed/21076134",
    "http://www.ncbi.nlm.nih.gov/pubmed/24667696",
    "http://www.ncbi.nlm.nih.gov/pubmed/25478006",
    "http://www.ncbi.nlm.nih.gov/pubmed/25238658",
    "http://www.ncbi.nlm.nih.gov/pubmed/21749752",
    "http://www.ncbi.nlm.nih.gov/pubmed/21574485",
    "http://www.ncbi.nlm.nih.gov/pubmed/26237478",
    "http://www.ncbi.nlm.nih.gov/pubmed/23470070",
    "http://www.ncbi.nlm.nih.gov/pubmed/21749753"
  ],
  "snippets": [
    {
      "text": "Non-invasive prenatal testing with cell-free DNA: US physician attitudes toward implementation in clinical practice.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23526649",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "The aim of this study was to assess awareness, potential adoption, and current utilization of non-invasive prenatal testing (NIPT) analysis for common fetal aneuploidies among obstetricians",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23526649",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Cell-free DNA has been used for fetal rhesus factor and sex determination, fetal aneuploidy screening, cancer diagnostics and monitoring, and other applications.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25543032",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The recent release of new, non-invasive prenatal tests for fetal aneuploidy using cell-free fetal DNA (cffDNA) has been hailed as a revolution in prenatal testing and has triggered significant commercial interest in the field.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22863603",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Non-invasive prenatal testing (NIPT) for aneuploidy using cell-free DNA in maternal plasma is revolutionizing prenatal screening and diagnosis.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23765643",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "SNP-based non-invasive prenatal testing detects sex chromosome aneuploidies with high accuracy.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23712453",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Non-invasive prenatal testing (NIPT) of cell-free fetal DNA in maternal plasma is a novel approach, designed for detecting common aneuploidies in the fetus.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25138112",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "This study aimed to develop a single-nucleotide polymorphism-based and informatics-based non-invasive prenatal test that detects sex chromosome aneuploidies early in pregnancy.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23712453",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "RAPIDR: an analysis package for non-invasive prenatal testing of aneuploidy.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24990604",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Non-invasive prenatal testing for aneuploidy: current status and future prospects.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23765643",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Non-invasive prenatal testing of fetal whole chromosome aneuploidy by massively parallel sequencing.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23299662",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Attitudes towards non-invasive prenatal testing for aneuploidy among US adults of reproductive age.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24603453",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "[Non-invasive prenatal test in the diagnosis of aneuploidy 13, 18 and 21--theoretical and practical aspects].",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21574485",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "To track and analyze two false positive cases from non-invasive prenatal testing for potential fetal aneuploidy.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25449088",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Non-invasive prenatal testing (NIPT) of fetal aneuploidy using cell-free fetal DNA is becoming part of routine clinical practice.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24990604",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "To report secondary or additional findings arising from introduction of non-invasive prenatal testing (NIPT) for aneuploidy by whole genome sequencing as a clinical service.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23553438",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Israeli Society of Medical Genetics NIPT Committee Opinion 072013: Non-invasive prenatal testing of cell-free DNA in maternal plasma for detection of fetal aneuploidy.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25138112",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "In recent years, technical advances in the molecular analysis of fetal DNA (e.g., digital PCR and massively parallel sequencing (MPS)) has enabled the successful implementation of noninvasive testing into clinical practice, such as fetal sex assessment, RhD genotyping, and fetal chromosomal aneuploidy detection.With the ability to decipher the entire fetal genome from maternal plasma DNA, we foresee that an increased number of non-invasive prenatal tests will be available for detecting many single-gene disorders in the near future",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24482806",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "First identified in 1997, cell-free fetal DNA (cffDNA) has just recently been used to detect fetal aneuploidy of chromosomes 13, 18, and 21, showing its potential to revolutionize prenatal genetic testing as a non-invasive screening tool",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24352524",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Non-invasive prenatal testing (NIPT) using cell-free fetal DNA in maternal plasma has been developed for the detection of fetal aneuploidy",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25238658",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Israeli Society of Medical Genetics NIPT Committee Opinion 072013: Non-invasive prenatal testing of cell-free DNA in maternal plasma for detection of fetal aneuploidy",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25138112",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Non-invasive prenatal testing for fetal aneuploidies in the first trimester of pregnancy",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25044397",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "To explore the value of next-generation sequencing for the non-invasive prenatal testing of fetal chromosomal aneuploidies",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/26252102",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Secondary findings from non-invasive prenatal testing for common fetal aneuploidies by whole genome sequencing as a clinical service",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23553438",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "To report secondary or additional findings arising from introduction of non-invasive prenatal testing (NIPT) for aneuploidy by whole genome sequencing as a clinical service",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23553438",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Secondary findings from non-invasive prenatal testing for common fetal aneuploidies by whole genome sequencing as a clinical service.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23553438",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Motivations for undertaking DNA sequencing-based non-invasive prenatal testing for fetal aneuploidy: a qualitative study with early adopter patients in Hong Kong.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24312358",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "OBJECTIVE: To determine whether non-invasive prenatal testing by maternal plasma DNA sequencing can uncover all fetal chromosome aneuploidies in one simple sequencing event. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23299662",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Non-invasive prenatal diagnosis of fetal aneuploidies using massively parallel sequencing-by-ligation and evidence that cell-free fetal DNA in the maternal plasma originates from cytotrophoblastic cells.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22500971",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Non-invasive prenatal testing (NIPT) using cell-free fetal DNA in maternal plasma has been developed for the detection of fetal aneuploidy.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25238658",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Non-invasive prenatal testing (NIPT) of cell-free fetal DNA in maternal plasma is a novel approach, designed for detecting common aneuploidies in the fetus.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25138112",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "non-invasive prenatal tests for fetal aneuploidy using cell-free fetal DNA (cffDNA) has been hailed as a revolution in prenatal testing and has triggered significant commercial interest in the field.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22863603",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": " Non-invasive prenatal testing (NIPT) of fetal aneuploidy using cell-free fetal DNA is becoming part of routine clinical practice. RAPIDR (Reliable Accurate Prenatal non-Invasive Diagnosis R package) is an easy-to-use open-source R package that implements several published NIPT analysis methods.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24990604",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The clinical data collected thus far indicate that NIPT is highly sensitive in detecting trisomies 21 and 18, and fairly sensitive in detecting trisomy 13 and sex chromosome aneuploidies. Because false-positive results may occur, an abnormal result must be validated by invasive prenatal testing.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25138112",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "When non-invasive prenatal screening for aneuploidy is available, maternal age alone should not be an indication for invasive prenatal diagnosis in a twin pregnancy. (II-2A) If non-invasive prenatal screening is not available, invasive prenatal diagnosis in twins should be offered to women aged 35 and over.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21749753",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Therefore, methods with high sensitivity and precision are required to detect and differentiate fetal DNA from the large background of maternal DNA. In recent years, technical advances in the molecular analysis of fetal DNA (e.g., digital PCR and massively parallel sequencing (MPS)) has enabled the successful implementation of noninvasive testing into clinical practice, such as fetal sex assessment, RhD genotyping, and fetal chromosomal aneuploidy detection.With the ability to decipher the entire fetal genome from maternal plasma DNA, we foresee that an increased number of non-invasive prenatal tests will be available for detecting many single-gene disorders in the near future.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24482806",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Non-invasive prenatal testing for fetal aneuploidies in the first trimester of pregnancy.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25044397",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Secondary findings from non-invasive prenatal testing for common fetal aneuploidies by whole genome sequencing as a clinical service.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23553438",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "To explore the value of next-generation sequencing for the non-invasive prenatal testing of fetal chromosomal aneuploidies.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/26252102",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "[Cell-free nucleic acid-based non-invasive prenatal diagnosis of fetal aneuploidies].",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23089167",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Maternal age alone is a poor minimum standard for prenatal screening for aneuploidy, and it should not be used a basis for recommending invasive testing when non-invasive prenatal screening for aneuploidy is available.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21749752",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Israeli Society of Medical Genetics NIPT Committee Opinion 072013: Non-invasive prenatal testing of cell-free DNA in maternal plasma for detection of fetal aneuploidy.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25138112",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Attitudes towards non-invasive prenatal testing for aneuploidy among US adults of reproductive age.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24603453",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "The recent release of new, non-invasive prenatal tests for fetal aneuploidy using cell-free fetal DNA (cffDNA) has been hailed as a revolution in prenatal testing and has triggered significant commercial interest in the field.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22863603",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Non-invasive prenatal testing (NIPT) of fetal aneuploidy using cell-free fetal DNA is becoming part of routine clinical practice.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24990604",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Non-invasive prenatal testing (NIPT) by massively parallel sequencing is a useful clinical test for the detection of common fetal aneuploidies.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24667696",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The clinical data collected thus far indicate that NIPT is highly sensitive in detecting trisomies 21 and 18, and fairly sensitive in detecting trisomy 13 and sex chromosome aneuploidies.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25138112",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [
    "http://www.nlm.nih.gov/cgi/mesh/2016/MB_cgi?field=uid&exact=Find+Exact+Term&term=D004247",
    "http://www.nlm.nih.gov/cgi/mesh/2016/MB_cgi?field=uid&exact=Find+Exact+Term&term=D011296"
  ],
  "exact_answer": "Yes"
}